secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allogene Therapeutics, Inc. (ALLO)
CIK:        0001737287
Form:       8-K
Filed at:   2023-04-20T23:59:59+00:00
Accession:  0001737287-23-000028
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Allogene CTO Alison Moore resigns; Tim Moore appointed as replacement
---------------------------------------------------------------------

- Alison Moore resigns as Chief Technical Officer effective April 28, 2023 to pursue other opportunities.
- Board appoints Tim Moore as CTO effective April 24, 2023; he will also provide transitional consulting.
- No further details on reasons for departure or consulting terms were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737287/000173728723000028/0001737287-23-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737287/000173728723000028/allo-20230418.htm
  HTML page:      https://secwatch.observer/filing/0001737287-23-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer